Pricing Log in Create free account
Friday 6 November 2026 Export GMED’s income statement to Excel — free account

Globus Medical, Inc.

GMED Healthcare Medical Devices

Globus Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 16.7% from fiscal 2024.

Revenue
−0.69%
EPS
+19.3%
Free cash flow
+10.1%

Quarter to September 2026, against a year earlier

72.16 9.28 −11.39%
Market cap
$10.9B
P/E
19.5×
Fwd P/E
18.8×
Dividend yield
—
F-score
9/9
Altman Z
11.30
Beneish M
−2.31
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Globus Medical, Inc. (GMED) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, Globus Medical, Inc. (GMED) trades at a price to free cash flow of 14.5×. Over the past ten years it has ranged from 13.2× (October 2026) to 78.7× (December 2015); the current reading is higher than 3% of that period. That is below the Medical Devices industry median of 28.8× and below the Healthcare sector median of 21.1×.

Price to free cash flow, daily

Embed this chart

Annual newest first

Period Price to free cash flow Change
FY2025 20.7× (25.11%)
FY2024 27.7× (23.86%)
FY2023 36.4× (48.31%)
FY2022 70.4× 112.32%
FY2021 33.2× (30.32%)
FY2020 47.6× (17.50%)
FY2019 57.7× 72.82%
FY2018 33.4× (13.45%)
FY2017 38.6× 73.86%
FY2016 22.2× (38.57%)

Quarterly newest first

Period Price to free cash flow Change
Sep 2026 13.5× (7.22%)
Jun 2026 14.5× (26.57%)
Mar 2026 19.7× (4.81%)
Dec 2025 20.7× 50.82%
43 more quarters

Against its own ten years

Low 13.2× High 78.7×
Ten-year median 39.7×
Current reading's percentile 3

Price to free cash flow against peers

Company Price to free cash flow
SNN Smith & Nephew SNATS, Inc. compare 7.1×
GMED Globus Medical, Inc. 14.5×
BIO Bio-Rad Laboratories, Inc. compare 30.0×
BIO.B Bio-Rad Laboratories, Inc. compare 30.7×
BRKR Bruker Corporation compare 32.9×
PODD Insulet Corporation compare 46.4×
PEN Penumbra, Inc. compare 63.1×
TXG 10x Genomics compare 63.3×
GKOS Glaukos Corporation compare 360×
Medical Devices industry median 28.8×
Healthcare sector median 21.1×
Market median 14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on GMED